Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2021 Apr 2

PMID 33796065

Citations 10

Authors

Sijie Chen

Chengcheng Niu

Qinghai Peng

Kui Tang

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to evaluate the usefulness of the sonographic characteristics of papillary thyroid carcinoma (PTC) with Hashimoto's thyroiditis (HT) for predicting central lymph node metastasis (CLNM). One hundred thirty-three patients who underwent thyroidectomy and central cervical lymph node dissection for PTC with coexistent HT were retrospectively analyzed. All PTCs with HT were preoperatively evaluated by ultrasound (US) regarding their nodular number, size, component, shape, margin, echogenicity, calcification, capsule contact with protrusion, vascularity and contrast enhanced ultrasound (CEUS) parameters. Univariate analysis demonstrated that patients with PTCs with HT and CLNM more frequently had age ≤ 45 years, size > 10 mm, a wider than tall shape, microcalcification, hypo-enhancement and peak intensity index < 1 than those without CLNM (all <0.05). Binary logistic regression analysis demonstrated that size > 10 mm and CEUS hypo-enhancement were independent characteristics for the presence of CLNM. Our study indicated that preoperative US characteristics could offer help in predicting CLNM in PTCs with coexistent HT.

Citing Articles

Predicting central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto's thyroiditis: a preoperative study.

Lou P, Huang Y, Li H, Zhao F, Xu J, Wang K BMC Cancer. 2025; 25(1):425.

PMID: 40065226 PMC: 11892260. DOI: 10.1186/s12885-025-13805-w.

A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: BRAF may not be a valuable predictor.

Chen Y, Zhao S, Zhang Z, Chen Z, Jiang B, An M Front Endocrinol (Lausanne). 2024; 15:1429382.

PMID: 39363900 PMC: 11446765. DOI: 10.3389/fendo.2024.1429382.

Predictors of lateral lymph node metastasis and skip metastasis in patients with papillary thyroid microcarcinoma.

Yoon J, Park J, Hong A, Kim H, Kang H Front Endocrinol (Lausanne). 2024; 15:1392247.

PMID: 39015180 PMC: 11250241. DOI: 10.3389/fendo.2024.1392247.

The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.

Lin Y, Cui N, Li F, Wang Y, Wang B Front Endocrinol (Lausanne). 2024; 15:1330896.

PMID: 38745958 PMC: 11091240. DOI: 10.3389/fendo.2024.1330896.

Diagnostic value of contrast-enhanced ultrasonography in the preoperative evaluation of lymph node metastasis in papillary thyroid carcinoma: a single-center retrospective study.

Yang Z, Wang X, Tao T, Zou J, Qiu Z, Wang L BMC Surg. 2023; 23(1):325.

PMID: 37875825 PMC: 10599078. DOI: 10.1186/s12893-023-02199-w.

References

Zhang Y, Zhou P, Tian S, Zhao Y, Li J, Li L . Usefulness of combined use of contrast-enhanced ultrasound and TI-RADS classification for the differentiation of benign from malignant lesions of thyroid nodules. Eur Radiol. 2016; 27(4):1527-1536. PMC: 5334375. DOI: 10.1007/s00330-016-4508-y. View

Ito Y, Kihara M, Takamura Y, Kobayashi K, Miya A, Hirokawa M . Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years. Endocr J. 2012; 59(7):539-45. DOI: 10.1507/endocrj.ej12-0086. View

Cho B, Choi H, Park Y, Lim J, Ahn H, Lee E . Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid. 2013; 23(7):797-804. PMC: 3704118. DOI: 10.1089/thy.2012.0329. View

Hong Y, Yan C, Mo G, Luo Z, Zhang Y, Wang Y . Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases. Sci Rep. 2015; 5:7748. PMC: 4291568. DOI: 10.1038/srep07748. View

Baek S, Jung K, Kang S, Kwon S, Woo J, Cho S . Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2009; 20(2):147-52. DOI: 10.1089/thy.2008.0243. View

Zhao Q, Ming J, Liu C, Shi L, Xu X, Nie X . Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol. 2012; 20(3):746-52. DOI: 10.1245/s10434-012-2654-2. View

Chen J, Li X, Zhao C, Wang D, Wang Q, Li M . Conventional Ultrasound, Immunohistochemical Factors and BRAF Mutation in Predicting Central Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma. Ultrasound Med Biol. 2018; 44(11):2296-2306. DOI: 10.1016/j.ultrasmedbio.2018.06.020. View

Liu W, Cheng R, Ma Y, Wang D, Su Y, Diao C . Establishment and validation of the scoring system for preoperative prediction of central lymph node metastasis in papillary thyroid carcinoma. Sci Rep. 2018; 8(1):6962. PMC: 5934378. DOI: 10.1038/s41598-018-24668-6. View

Deng J, Zhou P, Tian S, Zhang L, Li J, Qian Y . Comparison of diagnostic efficacy of contrast-enhanced ultrasound, acoustic radiation force impulse imaging, and their combined use in differentiating focal solid thyroid nodules. PLoS One. 2014; 9(3):e90674. PMC: 3940946. DOI: 10.1371/journal.pone.0090674. View

10.

Davies L, Welch H . Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014; 140(4):317-22. DOI: 10.1001/jamaoto.2014.1. View

11.

Khokhar M, Day K, Sangal R, Ahmedli N, Pisharodi L, Beland M . Preoperative High-Resolution Ultrasound for the Assessment of Malignant Central Compartment Lymph Nodes in Papillary Thyroid Cancer. Thyroid. 2015; 25(12):1351-4. DOI: 10.1089/thy.2015.0176. View

12.

Kim S, Lee B, Lee J, Kim S, Lee S, Jeon Y . Preoperative ultrasonographic tumor characteristics as a predictive factor of tumor stage in papillary thyroid carcinoma. Head Neck. 2011; 33(12):1719-26. DOI: 10.1002/hed.21658. View

13.

Jankovic B, Le K, Hershman J . Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation?. J Clin Endocrinol Metab. 2013; 98(2):474-82. DOI: 10.1210/jc.2012-2978. View

14.

Ma J, Ding H, Xu B, Xu C, Song L, Huang B . Diagnostic performances of various gray-scale, color Doppler, and contrast-enhanced ultrasonography findings in predicting malignant thyroid nodules. Thyroid. 2013; 24(2):355-63. DOI: 10.1089/thy.2013.0150. View

15.

Nam S, Shin J, Han B, Ko E, Ko E, Hahn S . Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior. J Clin Endocrinol Metab. 2013; 98(4):1476-82. DOI: 10.1210/jc.2012-4072. View

16.

Zaydfudim V, Feurer I, Griffin M, Phay J . The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery. 2008; 144(6):1070-7. DOI: 10.1016/j.surg.2008.08.034. View

17.

Lee D, Ji Y, Sung E, Park J, Lee Y, Park D . Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma. Eur J Surg Oncol. 2012; 39(2):191-6. DOI: 10.1016/j.ejso.2012.07.119. View

18.

Medas F, Canu G, Cappellacci F, Anedda G, Conzo G, Erdas E . Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients. Cancers (Basel). 2020; 12(6). PMC: 7353019. DOI: 10.3390/cancers12061658. View

19.

Lim H, Devesa S, Sosa J, Check D, Kitahara C . Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017; 317(13):1338-1348. PMC: 8216772. DOI: 10.1001/jama.2017.2719. View

20.

Cooper D, Doherty G, Haugen B, Hauger B, Kloos R, Lee S . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19(11):1167-214. DOI: 10.1089/thy.2009.0110. View